Company intelligence / Profile preview

Corridor Pharmaceuticals

Towson, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Corridor Pharmaceuticals is a biotechnology company located in Towson, Maryland, specializing in small molecule arginase inhibitors for cancer treatment. The company has three programs in development targeting arginase and serotonin receptor pathways for oncology, respiratory, autoimmune, and cardiovascular indications. All current programs are in pending stage.

Therapeutic areas: OncologyCardiovascularImmunologyPulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Corridor Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corridor Pharmaceuticals.

Explore the full profile